EOM 1352: Fri 7 June 2024, 11:36

Current Edition

ramusmedical
Europe

PCI Pharma Services Celebrates Success at Aspire Blaenau Gwent Shared Apprenticeship Awards

Aspire Blaenau Gwent Shared Apprenticeship Programme Award Winners 2018: PCI’s Macauley Webber (back r...
Continue Reading →
news

CAR-T cell update: Therapy improves outcomes for patients with B-cell lymphoma

In their phase-2 study of tisagenlecleucel (marketed as KYMRIAH®), to be published on-line Dec. 1, 2018 in the New England Journal of Medicine, an international team ...
Continue Reading →
news

Cannabis-based compound may reduce seizures in children with epilepsy

Interest has been growing in the use of cannabinoids - the active chemicals in cannabis or marijuana - for the treatment of epilepsy in children. A recent Epilepsia a...
Continue Reading →
Europe

Study: Chemotherapy agent did not improve survival in patients with triple-negative breast cancer

Treating patients who had early-stage triple-negative breast cancer with the chemotherapy agent capecitabine after they completed surgery and standard chemotherapy di...
Continue Reading →
Europe

Liraglutide drug associated with lower risk of cardiovascular events

Real world data from a large Nordic study shows that use of liraglutide, a drug for type 2 diabetes, is associated with a lower risk of myocardial infarction, stroke ...
Continue Reading →
Europe

iDD biotech receives second milestone payment from Genmab with enrollment of fifth patient in GEN1029 (HexaBody®-DR5/DR5) safety trial in patients with malignant solid tumors

Lyon, France, December 4, 2018 – iDD biotech, a French immuno-oncology company with a large pipeline of preclinical and clinical stage monoclonal antibodies, reports ...
Continue Reading →
Europe

Wearable technology could expand electrophysiology market to $2.6bn by 2028, says GlobalData

Following the news that Apple recently announced that 400,000 participants were enrolled in the Apple Heart trial, a study aimed at screening atrial fibrillation, She...
Continue Reading →
Europe

First Patient Successfully Implanted with Implandata’s Novel Eye Pressure Sensor for Continual Glaucoma Monitoring

Hannover, Germany, December 03, 2018 / B3C newswire / -- Ophthalmic medical device company Implandata Ophthalmic Products GmbH (Implandata) announced today that the f...
Continue Reading →
news

Polyphor announces positive results from the FDA Type B Guidance meeting on the planned Phase III study for balixafortide

The proposed study is intended to support the global registration of balixafortide. Polyphor expects to enroll the first patient in the second quarter of 2019. Polyph...
Continue Reading →
Europe

Botulinum toxin injections show promise to suppress postoperative atrial fibrillation

Postoperative atrial fibrillation (POAF) is a common complication, affecting one quarter to one half of all patients following cardiac surgery. It can result in heart...
Continue Reading →
Quotient